Tech Company Financing Transactions
LAM Therapeutics Funding Round
LAM Therapeutics closed a $58 million Series C funding round on 4/3/2017. Backers included private investors.
Transaction Overview
Company Name
Announced On
4/3/2017
Transaction Type
Venture Equity
Amount
$58,000,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
530 Old Whitfield St.
Guilford, CT 06437
USA
Guilford, CT 06437
USA
Phone
Website
Email Address
Overview
LAM accelerates drug development by deploying technologies including genome editing, chemical genomics, artificial intelligence (AI) and combinational drug screening to match clinical drugs to new indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Henri Lichenstein
VP - R & D
Peter Young
Browse more venture capital transactions:
Prev: 4/3/2017: Pigeonly venture capital transaction
Next: 4/3/2017: Cymbet venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs